Table 1 Clinical characteristics of LN patients
Terms | LN-1 | LN-2 | LN-3 | LN-4 | LN-5 |
|---|---|---|---|---|---|
Age/gender | 32/F | 34/F | 31/F | 22/F | 37/F |
Disease duration (month) | 12 | 108 | 24 | 22 | 36 |
SLEDAI-2K Score | 20 | 22 | 16 | 30 | 15 |
Clinical characteristics | |||||
Alopecia | + | + | − | + | − |
Rash | − | + | + | + | + |
Arthritis | + | + | − | + | + |
Myositis | + | + | + | + | − |
Antibody | |||||
ANA | + | + | + | + | + |
Anti-dsDNA antibody | + | + | + | + | + |
Anti-Sm antibody | + | + | − | − | − |
Renal pathology | Class IV + V | Class IV + V | Class III + V | Class III + V | Class IV |
Concomitant medications before MSCT | |||||
Prednisone dose or equivalent, mg/day | 15 | 5 | 10 | 15 | 15 |
HCQ, mg/day | 300 | 400 | 200 | 400 | 300 |
